NCT00128297View on ClinicalTrials.gov

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

PHASE4CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 18, 2000

Primary Completion Date

June 4, 2004

Study Completion Date

June 4, 2004

Conditions
Breast CancerNeoplasm Metastasis
Interventions
DRUG

Pamidronate

Trial Locations (1)

28700

Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER